150 related articles for article (PubMed ID: 6586630)
1. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species.
Gray RH; de la Iglesia FA
Hepatology; 1984; 4(3):520-30. PubMed ID: 6586630
[TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment.
De La Iglesia FA; Lewis JE; Buchanan RA; Marcus EL; McMahon G
Atherosclerosis; 1982 May; 43(1):19-37. PubMed ID: 6807326
[TBL] [Abstract][Full Text] [Related]
3. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
[TBL] [Abstract][Full Text] [Related]
4. Zonal heterogeneity of peroxisome proliferation and morphology in rat liver after gemfibrozil treatment.
Gorgas K; Krisans SK
J Lipid Res; 1989 Dec; 30(12):1859-75. PubMed ID: 2621413
[TBL] [Abstract][Full Text] [Related]
5. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
[TBL] [Abstract][Full Text] [Related]
6. Effect of gemfibrozil on centrifugal behavior of rat peroxisomes and activities of peroxisomal enzymes involved in lipid metabolism.
Hashimoto F; Hamada S; Hayashi H
Biol Pharm Bull; 1997 Apr; 20(4):315-21. PubMed ID: 9145201
[TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
8. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
Hall MJ; Nelson LM; Russell RI; Howard AN
Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
[TBL] [Abstract][Full Text] [Related]
9. Hepatotumorigenicity and peroxisome proliferation induced by the hypolipidemic CI-924 in a two-year study in male and female B6C3F1 mice.
Walker RM; Wojcinski ZW; Hofstra AH; King LM; Rogers JE; Baker KW; Chang PK; Smith GS
Toxicol Pathol; 1996; 24(3):265-72. PubMed ID: 8736381
[TBL] [Abstract][Full Text] [Related]
10. Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver: a morphometric/stereologic study by electron microscopy.
Fringes B; Reith A
Lab Invest; 1982 Jul; 47(1):19-26. PubMed ID: 7087394
[TBL] [Abstract][Full Text] [Related]
11. Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects.
Leiss O; von Bergmann K; Gnasso A; Augustin J
Metabolism; 1985 Jan; 34(1):74-82. PubMed ID: 3855325
[TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F344 rats.
Sausen PJ; Teets VJ; Voss KS; Miller RT; Cattley RC
Cancer Lett; 1995 Nov; 97(2):263-8. PubMed ID: 7497472
[TBL] [Abstract][Full Text] [Related]
13. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
14. Hepatic peroxisome proliferation in rodents and its significance for humans.
Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
[TBL] [Abstract][Full Text] [Related]
15. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
Amacher DE; Beck R; Schomaker SJ; Kenny CV
Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
[TBL] [Abstract][Full Text] [Related]
16. Difference between species in response to a 3,5-dichloropyridyloxyphenoxy compound: induction of cytochrome P-450 and/or peroxisome proliferation.
Schmidt U; Machemer L
Food Addit Contam; 1989; 6 Suppl 1():S41-55. PubMed ID: 2599155
[TBL] [Abstract][Full Text] [Related]
17. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
Maxwell RE; Nawrocki JW; Uhlendorf PD
Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes.
Watanabe T; Horie S; Yamada J; Isaji M; Nishigaki T; Naito J; Suga T
Biochem Pharmacol; 1989 Jan; 38(2):367-71. PubMed ID: 2914022
[TBL] [Abstract][Full Text] [Related]
19. Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes.
Usuda N; Reddy MK; Hashimoto T; Rao MS; Reddy JK
Lab Invest; 1988 Jan; 58(1):100-11. PubMed ID: 3336202
[TBL] [Abstract][Full Text] [Related]
20. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
